Patent · US Active

HPV particles and uses thereof

US9724404B2 · kind B2 · utility

10Cited by

14References

13Claims

0Family size

Assignees

INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR
Aura Biosciences, Inc. · US

Inventors

Pierre L. Coursaget · Paris, FR
Antoine A. Touzé · Tours, FR
Maxime J. J. Fleury · Tours, FR
Nicolas Combelas · Tours, FR
Elisabet de los Pinos · Brookline, US

Key dates

Filing date	Jul 24, 2009
Grant date	Aug 8, 2017
Priority date	—
Expiry date	Apr 22, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2800/22
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to modified HPV particles that can be used therapeutically. Modified HPV particles may be used to deliver therapeutic agents, including siRNA molecules. Modified HPV particles may be used for the treatment of diseases or conditions of mucosal tissue, including HPV (human papilloma virus) infection and HPV-related tumors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.